// App-Quantinova.ai

: The Leicester Cough Questionnaire in two phase 3 trials of gefapixant in chronic cough

Researchers

Presenter

  • Surinder S. Birring

Principal Investigators

  • Jaclyn A. Smith

  • Alyn Morice

  • Ian Pavord

  • Peter V Dicpinigaitis

  • Lorcan Mcgarvey

  • Anjela Tzontcheva

  • Qing Li

  • Allison Martin Nguyen

  • Jonathan Schelfhout

  • David Muccino

  • Carmen La Rosa

Medical Centers

  • Oxford NIHR Respiratory BRC, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

  • Merck & Co., Inc., Kenilworth, United States of America

  • Centre for Human & Applied Physiological Sciences, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King’s College London, London, United Kingdom

  • University of Manchester and Manchester University NHS Trust, University of MancManchester, United Kingdom

  • Albert Einstein College of Medicine and Montefiore Headache Center Bronx NY United States

  • Wellcome-Wolfson Institute of Experimental Medicine, Queen's University Belfast, Belfast, United Kingdom

  • The Hull York Medical School, Cottingham, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • Gefapixant

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • III

Study Id's

  • NCT03449134

  • NCT3449147

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved